Select Service: Keys to Effective Jury Selection in Pharmaceutical and Biotech Litigation


While public understanding of the intricacies of the jury selection process is unlikely to be much more complicated than the fictionalized version you might see in a John Grisham novel, litigators—as well as decision-makers in the pharmaceutical and biotech fields, in particular—rely on a much more nuanced and sophisticated set of priorities when it comes to jury selection.
[Read more…]

Capitalizing on the Affordable Care Act: Are You Ready?


The implementation of the Affordable Care Act (ACA) presents a host of challenges and opportunities for pharmaceutical manufacturers. While estimates of the impact to the pharmaceutical industry vary widely, one thing is clear – ACA has put in motion a number of dynamic changes that will transform the U.S. healthcare marketplace. Given the recent rocky rollout of the Federal web site and strong opposition to ACA, there will no doubt be many changes to the regulations in the near future. The full impact of ACA may not be known for years, but pharmaceutical companies need to prepare now to ensure their business models and processes are ready to compete effectively in the changing healthcare environment.
[Read more…]

Trends in IT Compliance

Life science companies are increasingly leveraging information technology to streamline the process of bringing quality products to market. Regulatory compliance, quality and accuracy of data and documentation, and good record keeping are paramount.
[Read more…]